<p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）在周三发布的报告中，投资分析师将其目标股价从 93.00 美元上调至 95.00 美元，MarketScreener 报道。该公司目前对这家药房运营商的股票给予 “买入” 评级。摩根士丹利的目标价暗示该股票相较于之前的收盘价有 21.03% 的潜在上涨空间。</p>
<ul>
<li>CVS Health 因收入增长而上涨，股息保持强劲</li>
</ul>
<p>其他一些股票分析师也最近对该公司发表了看法。Raymond James Financial 在 10 月 31 日的报告中将 CVS Health 的目标股价从 75.00 美元上调至 90.00 美元。Wolfe Research 在周一将 CVS Health 的目标股价从 85.00 美元上调至 100.00 美元，并给予该股票 “跑赢大盘” 的评级。Weiss Ratings 在周一的研究报告中重申了对 CVS Health 股票的 “持有（c-）” 评级。Mizuho 在周三将 CVS Health 的目标股价从 88.00 美元上调至 95.00 美元，并给予该股票 “跑赢大盘” 的评级。最后，巴克莱在周三将 CVS Health 的目标价从 87.00 美元上调至 93.00 美元，并给予该公司 “增持” 评级。有两位分析师给予该股票 “强烈买入” 评级，二十位分析师给予 “买入” 评级，四位分析师给予 “持有” 评级。根据 MarketBeat 的数据，CVS Health 的平均评级为 “适度买入”，平均目标股价为 93.43 美元。</p>
<p><strong>获取我们关于 CVS Health 的最新研究报告</strong></p>
<h2>CVS Health 价格表现</h2>
<ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
<p>纽约证券交易所：CVS 在周三开盘价为 78.50 美元。该公司的 50 日移动平均价格为 78.87 美元，200 日移动平均价格为 71.64 美元。CVS Health 的 1 年最低价为 43.56 美元，1 年最高价为 85.15 美元。该公司的市值为 996.5 亿美元，市盈率为 208.57，市盈增长比率为 0.76，贝塔系数为 0.48。该公司的债务股本比率为 0.83，流动比率为 0.83，速动比率为 0.63。</p>
<p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）在 10 月 29 日周三发布了季度财报。该药房运营商报告季度每股收益为 1.60 美元，超出市场共识预期的 1.36 美元，超出 0.24 美元。该公司季度收入为 1028.7 亿美元，而分析师预期为 988.5 亿美元。CVS Health 的净利润率为 0.12%，股本回报率为 11.45%。该公司的收入同比增长 7.8%。去年同期，该公司每股收益为 1.09 美元。CVS Health 已将其 2025 财年的指导目标设定为 6.550-6.650 美元每股收益。股票研究分析师预测 CVS Health 在当前年度将发布 5.89 美元每股收益。</p>
<h2>CVS Health 的机构交易</h2>
<ul>
<li>现在是买入 Novo Nordisk 股票的时机吗？</li>
</ul>
<p>大型投资者最近买入和卖出了该公司的股票。Severin Investments LLC 在第三季度将其在 CVS Health 的持股比例提高了 124.9%。Severin Investments LLC 现在拥有 14,789 股该药房运营商的股票，价值 1,115,000 美元，此前在上个季度购买了 8,212 股。Allworth Financial LP 在第三季度将其在 CVS Health 的持股增加了 7.2%。Allworth Financial LP 现在拥有 28,764 股该药房运营商的股票，价值 2,169,000 美元，此前在上个季度购买了 1,922 股。IFP Advisors Inc 在第三季度将其在 CVS Health 的持股提高了 5.6%。IFP Advisors Inc 现在拥有 25,463 股该药房运营商的股票，价值 1,920,000 美元，此前在上个季度购买了 1,345 股。Steadtrust LLC 在第三季度将其在 CVS Health 的持股提高了 1.8%。Steadtrust LLC 现在拥有 10,175 股该药房运营商的股票，价值 767,000 美元，此前在上个季度购买了 175 股。最后，CIBC Bancorp USA Inc.在第三季度购买了 CVS Health 的新股份，价值 13,183,000 美元。对冲基金和其他机构投资者持有该公司 80.66% 的股份。</p>
<h2>CVS Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>股息贵族名单中的最佳：通过贵族指数积累财富</li>
<li>错过了 NVIDIA？Braze 可能是下一个 AI 股票突破</li>
<li>如何交易便士股票：逐步指南</li>
<li>沃尔玛的纳斯达克切换可能改变 WMT 股票的一切</li>
<li>万亿美元市值的意义超越数字本身</li>
<li>GameStop 看起来破碎：这就是为什么 GME 可能在 2026 年崩溃</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 CVS Health 不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西维斯

<p>高盛将 CVS Health 的目标股价从 93 美元上调至 95 美元，维持 “买入” 评级，暗示潜在上涨幅度为 21.03%。其他分析师也提高了他们的目标，CVS Health 获得了 “适度买入” 的平均评级。该公司报告了强劲的季度收益，营收同比增长 7.8%。机构投资者积极交易 CVS Health 的股票，持股比例达到 80.66%。CVS Health 在医疗保健福利、服务和药房领域运营</p>

<p>CVS Health (NYSE:CVS - Get Free Report) had its price target raised by investment analysts at The Goldman Sachs Group from $93.00 to $95.00 in a report issued on Wednesday,MarketScreener reports. The firm presently has a &#34;buy&#34; rating on the pharmacy operator's stock. The Goldman Sachs Group's price objective suggests a potential upside of 21.03% from the stock's previous close.</p>
<div class="lb-trans"><p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）在周三发布的报告中，投资分析师将其目标股价从 93.00 美元上调至 95.00 美元，MarketScreener 报道。该公司目前对这家药房运营商的股票给予 “买入” 评级。摩根士丹利的目标价暗示该股票相较于之前的收盘价有 21.03% 的潜在上涨空间。</p>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 因收入增长而上涨，股息保持强劲</li>
</ul>
</div><p>A number of other equities analysts have also recently weighed in on the company. Raymond James Financial upped their price target on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Wolfe Research upped their target price on CVS Health from $85.00 to $100.00 and gave the stock an &#34;outperform&#34; rating in a research note on Monday. Weiss Ratings reiterated a &#34;hold (c-)&#34; rating on shares of CVS Health in a research report on Monday. Mizuho boosted their price target on shares of CVS Health from $88.00 to $95.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday. Finally, Barclays increased their price objective on shares of CVS Health from $87.00 to $93.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, CVS Health has an average rating of &#34;Moderate Buy&#34; and an average target price of $93.43.</p>
<div class="lb-trans"><p>其他一些股票分析师也最近对该公司发表了看法。Raymond James Financial 在 10 月 31 日的报告中将 CVS Health 的目标股价从 75.00 美元上调至 90.00 美元。Wolfe Research 在周一将 CVS Health 的目标股价从 85.00 美元上调至 100.00 美元，并给予该股票 “跑赢大盘” 的评级。Weiss Ratings 在周一的研究报告中重申了对 CVS Health 股票的 “持有（c-）” 评级。Mizuho 在周三将 CVS Health 的目标股价从 88.00 美元上调至 95.00 美元，并给予该股票 “跑赢大盘” 的评级。最后，巴克莱在周三将 CVS Health 的目标价从 87.00 美元上调至 93.00 美元，并给予该公司 “增持” 评级。有两位分析师给予该股票 “强烈买入” 评级，二十位分析师给予 “买入” 评级，四位分析师给予 “持有” 评级。根据 MarketBeat 的数据，CVS Health 的平均评级为 “适度买入”，平均目标股价为 93.43 美元。</p>
</div><p><strong>Get Our Latest Research Report on CVS Health</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 CVS Health 的最新研究报告</strong></p>
</div><h2>CVS Health Price Performance</h2>
<div class="lb-trans"><h2>CVS Health 价格表现</h2>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
</div><p>NYSE:CVS opened at $78.50 on Wednesday. The company has a 50 day moving average price of $78.87 and a 200-day moving average price of $71.64. CVS Health has a 1-year low of $43.56 and a 1-year high of $85.15. The firm has a market cap of $99.65 billion, a price-to-earnings ratio of 208.57, a price-to-earnings-growth ratio of 0.76 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.</p>
<div class="lb-trans"><p>纽约证券交易所：CVS 在周三开盘价为 78.50 美元。该公司的 50 日移动平均价格为 78.87 美元，200 日移动平均价格为 71.64 美元。CVS Health 的 1 年最低价为 43.56 美元，1 年最高价为 85.15 美元。该公司的市值为 996.5 亿美元，市盈率为 208.57，市盈增长比率为 0.76，贝塔系数为 0.48。该公司的债务股本比率为 0.83，流动比率为 0.83，速动比率为 0.63。</p>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm's revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the business earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts forecast that CVS Health will post 5.89 EPS for the current year.</p>
<div class="lb-trans"><p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）在 10 月 29 日周三发布了季度财报。该药房运营商报告季度每股收益为 1.60 美元，超出市场共识预期的 1.36 美元，超出 0.24 美元。该公司季度收入为 1028.7 亿美元，而分析师预期为 988.5 亿美元。CVS Health 的净利润率为 0.12%，股本回报率为 11.45%。该公司的收入同比增长 7.8%。去年同期，该公司每股收益为 1.09 美元。CVS Health 已将其 2025 财年的指导目标设定为 6.550-6.650 美元每股收益。股票研究分析师预测 CVS Health 在当前年度将发布 5.89 美元每股收益。</p>
</div><h2>Institutional Trading of CVS Health</h2>
<div class="lb-trans"><h2>CVS Health 的机构交易</h2>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>现在是买入 Novo Nordisk 股票的时机吗？</li>
</ul>
</div><p>Large investors have recently bought and sold shares of the business. Severin Investments LLC lifted its stake in CVS Health by 124.9% in the 3rd quarter. Severin Investments LLC now owns 14,789 shares of the pharmacy operator's stock worth $1,115,000 after purchasing an additional 8,212 shares in the last quarter. Allworth Financial LP increased its holdings in shares of CVS Health by 7.2% in the third quarter. Allworth Financial LP now owns 28,764 shares of the pharmacy operator's stock valued at $2,169,000 after purchasing an additional 1,922 shares during the last quarter. IFP Advisors Inc lifted its position in CVS Health by 5.6% during the third quarter. IFP Advisors Inc now owns 25,463 shares of the pharmacy operator's stock worth $1,920,000 after buying an additional 1,345 shares in the last quarter. Steadtrust LLC boosted its stake in CVS Health by 1.8% during the third quarter. Steadtrust LLC now owns 10,175 shares of the pharmacy operator's stock worth $767,000 after buying an additional 175 shares during the last quarter. Finally, CIBC Bancorp USA Inc. purchased a new stake in CVS Health in the 3rd quarter valued at $13,183,000. Hedge funds and other institutional investors own 80.66% of the company's stock.</p>
<div class="lb-trans"><p>大型投资者最近买入和卖出了该公司的股票。Severin Investments LLC 在第三季度将其在 CVS Health 的持股比例提高了 124.9%。Severin Investments LLC 现在拥有 14,789 股该药房运营商的股票，价值 1,115,000 美元，此前在上个季度购买了 8,212 股。Allworth Financial LP 在第三季度将其在 CVS Health 的持股增加了 7.2%。Allworth Financial LP 现在拥有 28,764 股该药房运营商的股票，价值 2,169,000 美元，此前在上个季度购买了 1,922 股。IFP Advisors Inc 在第三季度将其在 CVS Health 的持股提高了 5.6%。IFP Advisors Inc 现在拥有 25,463 股该药房运营商的股票，价值 1,920,000 美元，此前在上个季度购买了 1,345 股。Steadtrust LLC 在第三季度将其在 CVS Health 的持股提高了 1.8%。Steadtrust LLC 现在拥有 10,175 股该药房运营商的股票，价值 767,000 美元，此前在上个季度购买了 175 股。最后，CIBC Bancorp USA Inc.在第三季度购买了 CVS Health 的新股份，价值 13,183,000 美元。对冲基金和其他机构投资者持有该公司 80.66% 的股份。</p>
</div><h2>CVS Health Company Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy &amp; Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p>
<div class="lb-trans"><p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li>
<li>Missed NVIDIA? Braze Might Be the Next AI Stock Breakout</li>
<li>How to trade penny stocks: A step-by-step guide</li>
<li>Walmart’s NASDAQ Switch Could Change Everything for WMT Stock</li>
<li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li>
<li>GameStop Looks Broken: Here’s Why GME Could Crash in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>股息贵族名单中的最佳：通过贵族指数积累财富</li>
<li>错过了 NVIDIA？Braze 可能是下一个 AI 股票突破</li>
<li>如何交易便士股票：逐步指南</li>
<li>沃尔玛的纳斯达克切换可能改变 WMT 股票的一切</li>
<li>万亿美元市值的意义超越数字本身</li>
<li>GameStop 看起来破碎：这就是为什么 GME 可能在 2026 年崩溃</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 CVS Health 不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

高盛集团将西维斯（NYSE:CVS）的目标价上调至 95.00 美元